Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : BAX save search
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published: 2024-03-18 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.02%
H: 1.03%
C: 0.96%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.11%
H: 0.59%
C: 0.1%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.48%
H: 0.31%
C: 0.13%
reach cancer treatment global market
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.51%
H: 0.13%
C: -1.68%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.14%
H: 0.78%
C: 0.22%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.73%
H: 0.06%
C: -1.38%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.2%
H: 0.2%
C: -0.76%
GOOGL | News S | $154.08 -1.24% -1.25% 32M
|
Technology Services
|
| O: 1.97%
H: 0.0%
C: 0.0%
GOOG | News S | $155.7 -1.12% -1.13% 20M
|
Technology Services
|
| O: 1.97%
H: 0.0%
C: 0.0%
ADBE | News A | $465.03 -1.72% -1.75% 3M
|
Technology Services
|
| O: 0.97%
H: 0.08%
C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market
Doxorubicin market size to grow by USD 469.97 million from 2022 to 2027; Growth driven by increasing prevalence of cancer cases - Technavio
Published: 2023-05-05 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.77%
H: 1.03%
C: 0.88%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.55%
H: 1.38%
C: 1.12%
cancer doxorubicin growth market
Oncology market size in India to grow by USD 947.84 million between 2022 and 2027; Growth driven by increased prevalence of cancer - Technavio
Published: 2023-05-02 (Crawled : 07:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: -0.44%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.57%
H: 1.69%
C: 1.55%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.53%
H: 0.88%
C: 0.03%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: -0.4%
H: 0.81%
C: -0.38%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.05%
H: 0.79%
C: 0.4%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.71%
H: 1.09%
C: 0.99%
GOOGL | News S | $154.08 -1.24% -1.25% 32M
|
Technology Services
|
| O: -0.06%
H: 0.06%
C: -1.7%
GOOG | News S | $155.7 -1.12% -1.13% 20M
|
Technology Services
|
| O: -0.05%
H: 0.07%
C: -1.56%
india cancer growth market
Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Published: 2023-03-24 (Crawled : 19:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
SGEN | $228.74 0.1% 20M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
cancer growing therapeutics market
Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio
Published: 2023-02-20 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
RLFTY | $1.4006 733.33% 100
|
n/a
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
RLFTF | $1.43 11.45% 3.8K
|
n/a
| Email alert
Add to watchlist
america care cancer growth market
Fallopian Tube Cancer Therapeutics Market Research Report by Technavio predicts USD 628.28 Mn growth | North America to have a significant share
Published: 2022-08-29 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -2.7%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.39%
H: 0.05%
C: -0.9%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.33%
H: 0.45%
C: 0.09%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: -0.65%
H: 0.92%
C: 0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.11%
H: 0.38%
C: -0.36%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.75%
H: 0.92%
C: 0.23%
america research tube report therapeutics cancer growth market
Cancer Supportive Care Market Size to Grow by USD 4.98 Billion | Market Research Insights Highlight Growing Prevalence of Cancer Cases as Key Driver | Technavio
Published: 2022-02-01 (Crawled : 05:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: 0.42%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -0.77%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.39%
H: 0.24%
C: 0.19%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.22%
H: 0.91%
C: 0.68%
research cancer growing
Cancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research
Published: 2022-01-20 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.95%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.78%
H: 0.0%
C: 0.0%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: -0.27%
H: 2.1%
C: 0.27%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: -2.07%
drug research cancer
Merrimack Pharmaceuticals Announces Initiation of Phase 1 Clinical Study of MM-398 for Brain Cancer
Published: 2014-11-06 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.72 0.27% 0.27% 76K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
phase 1 cancer brain cancer phase 3 phase 2 train
Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer
Published: 2014-11-19 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.72 0.27% 0.27% 76K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
fda fda fast track fast track cancer pancreatic fast track designation gemcitabine pancreas designation
Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398, Nanoliposomal Irinotecan (nal-IRI), Published in Cancer Research
Published: 2014-12-04 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.72 0.27% 0.27% 76K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
cancer research preclinical pre-clinical
Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium
Published: 2015-01-20 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.72 0.27% 0.27% 76K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
test cancer gastrointestinal phase 3 symposium
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.